Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.

Mueller AM, Pedré X, Kleiter I, Hornberg M, Steinbrecher A, Giegerich G.

J Neuroimmunol. 2005 Feb;159(1-2):55-65. Epub 2004 Nov 18.

PMID:
15652403
2.

Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis.

Desplat-Jégo S, Creidy R, Varriale S, Allaire N, Luo Y, Bernard D, Hahm K, Burkly L, Boucraut J.

Clin Immunol. 2005 Oct;117(1):15-23.

PMID:
16027043
3.

Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kojima Y, Harada N, Kominami E, Okumura K, Yagita H.

J Immunol. 2003 Jan 1;170(1):341-8.

4.

Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells.

Harada N, Nakayama M, Nakano H, Fukuchi Y, Yagita H, Okumura K.

Biochem Biophys Res Commun. 2002 Dec 6;299(3):488-93.

PMID:
12445828
5.

Amelioration of autoimmune neuroinflammation by the fusion molecule Fn14·TRAIL.

Prinz-Hadad H, Mizrachi T, Irony-Tur-Sinai M, Prigozhina TB, Aronin A, Brenner T, Dranitzki-Elhalel M.

J Neuroinflammation. 2013 Mar 9;10:36. doi: 10.1186/1742-2094-10-36.

6.

TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.

Polek TC, Talpaz M, Darnay BG, Spivak-Kroizman T.

J Biol Chem. 2003 Aug 22;278(34):32317-23. Epub 2003 Jun 6.

7.

Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.

Mustonen E, Säkkinen H, Tokola H, Isopoussu E, Aro J, Leskinen H, Ruskoaho H, Rysä J.

Acta Physiol (Oxf). 2010 May;199(1):11-22. doi: 10.1111/j.1748-1716.2010.02080.x. Epub 2010 Jan 16.

PMID:
20082609
8.

IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.

Klein RS, Izikson L, Means T, Gibson HD, Lin E, Sobel RA, Weiner HL, Luster AD.

J Immunol. 2004 Jan 1;172(1):550-9.

9.

TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity.

Desplat-Jégo S, Varriale S, Creidy R, Terra R, Bernard D, Khrestchatisky M, Izui S, Chicheportiche Y, Boucraut J.

J Neuroimmunol. 2002 Dec;133(1-2):116-23.

PMID:
12446014
10.

TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.

Dohi T, Borodovsky A, Wu P, Shearstone JR, Kawashima R, Runkel L, Rajman L, Dong X, Scott ML, Michaelson JS, Jakubowski A, Burkly LC.

Gastroenterology. 2009 Mar;136(3):912-23. doi: 10.1053/j.gastro.2008.11.017. Epub 2008 Nov 8.

PMID:
19109961
11.

Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.

Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.

Clin Exp Immunol. 2006 Dec;146(3):540-9.

12.

Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.

Kataria NG, Bartold PM, Dharmapatni AA, Atkins GJ, Holding CA, Haynes DR.

J Periodontal Res. 2010 Aug;45(4):564-73. doi: 10.1111/j.1600-0765.2010.01275.x. Epub 2010 Jun 10.

PMID:
20546112
13.

Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.

Lobell A, Weissert R, Eltayeb S, de Graaf KL, Wefer J, Storch MK, Lassmann H, Wigzell H, Olsson T.

J Immunol. 2003 Feb 15;170(4):1806-13.

14.

TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.

Burkly LC, Michaelson JS, Zheng TS.

Immunol Rev. 2011 Nov;244(1):99-114. doi: 10.1111/j.1600-065X.2011.01054.x. Review.

PMID:
22017434
15.

FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.

Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N.

Basic Res Cardiol. 2010 Mar;105(2):301-13. doi: 10.1007/s00395-009-0046-y. Epub 2009 Jul 23.

PMID:
19629561
16.

Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts.

Ebihara N, Nakayama M, Tokura T, Ushio H, Murakami A.

Exp Eye Res. 2009 Aug;89(2):256-62. doi: 10.1016/j.exer.2009.03.014. Epub 2009 Apr 1.

PMID:
19344712
17.

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor.

Wiley SR, Winkles JA.

Cytokine Growth Factor Rev. 2003 Jun-Aug;14(3-4):241-9. Review.

PMID:
12787562
18.

TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.

Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.

Arthritis Res Ther. 2006;8(5):R146.

19.

Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.

Ebihara N, Nakayama M, Tokura T, Iwatsu M, Ushio H, Murakami A.

Curr Eye Res. 2009 Oct;34(10):836-44. doi: 10.3109/02713680903122037.

PMID:
19895311
20.

Tumor necrosis factor-like weak inducer of apoptosis induces astrocyte proliferation through the activation of transforming-growth factor-α/epidermal growth factor receptor signaling pathway.

Rousselet E, Traver S, Monnet Y, Perrin A, Mandjee N, Hild A, Hirsch EC, Zheng TS, Hunot S.

Mol Pharmacol. 2012 Nov;82(5):948-57. doi: 10.1124/mol.112.079608. Epub 2012 Aug 21.

Supplemental Content

Support Center